addressing delivery hurdles in the translation of oligonucleotide therapeutics
Published 7 years ago • 1.8K plays • Length 31:01Download video MP4
Download video MP3
Similar videos
-
35:00
quantification methods for oligonucleotide therapeutics in serum and tissue
-
23:35
antisense oligonucleotide therapy
-
58:52
delivery of macromolecular therapeutics: tackling a billion year old barrier
-
33:21
chemistry of therapeutic oligonucleotides: a brief overview
-
19:33
oligo meeting 2017 - rnai drug discovery
-
54:11
shalini andersson: developing oligonucleotides into therapies
-
1:12:47
circular rna immunity
-
1:06:13
targeted delivery using aptamers
-
34:19
manufacturing oligonucleotides from bench to bed
-
23:23
oligonucleotides as a new therapeutic class: progress report & prescription
-
22:47
chemistry of oligonucleotide therapeutics 101
-
1:02:53
art krieg: how to test for immune activation by your therapeutic oligonucleotide
-
30:55
nonclinical strategies for oligonucleotide development programs
-
20:32
12th annual meeting of the oligonucleotide therapeutic society
-
12:26
asf scientific symposium: hurdles to be overcome for a trial of oligonucleotide therapy in as
-
1:01:28
chemical and nanotechnology based approaches to build next gen oligonucleotide therapeutics
-
1:02:39
mano manoharan: the world of galnac conjugates in nucleic acid therapeutics
-
1:01:51
pitfalls and progress in the development of immune stimulatory nucleic acids
-
32:24
drug development process - tox, adme, pk/pd, clinical poc and drug approval
-
1:16:45
antisense oligonucleotides- mechanisms of action and rational design
-
59:12
oligo meeting 2017 - keynote presentation